The health technology company offers a platform that enables clinicians to more quickly and accurately complete specialty drug enrollment processes. The goal is to simplify the administrative burden on providers and get patients quicker access to the medications they need.
This post is part of ongoing coverage of Cleveland Clinic’s 2013 Medical Innovation Summit: Finding Balance through Innovation. Obesity, Diabetes & the Metabolic Crisis. During a panel discussion with other doctors and drug industry executives, William Herman, MD, made a statement that seemed pretty innocuous. “I think the key to controlling diabetes is prevention.” Preventative […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This post is part of ongoing coverage of Cleveland Clinic’s 2013 Medical Innovation Summit: Finding Balance through Innovation. Obesity, Diabetes & the Metabolic Crisis. Two newly approved pharmaceuticals – and others in development – may be elemental in a broader treatment strategy to reverse the worldwide obesity problem, a panel of pharmaceutical company executives says. […]